Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence

Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence

A randomized study to evaluate the safety and effects of transanal submucosal polyacrylamide hydrogel injection therapy for anal incontinence.

A prospective randomized study to assess the use of Bulkamid for anal incontinence using three different transanal injection techniques .

Patients with anal incontinence severity Wexner score >7. Standardised injection treatment at baseline. Clinical status and subjective symptom evaluation (Wexner score and FIQL) at baseline, 2 months, 6 months and 1 year.

Inclusion Criteria:

• informed consent, anal incontinence with Wexner score >10

Exclusion Criteria:

• ino additional pregnancies, schedule for pelvic organ surgery within 1 year of treatment, current or previous pelvic organ cancer, insulin treated diabetes, inflammatory bowel disease